Previous close | 0.0210 |
Open | 0.0240 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0140 - 0.0240 |
52-week range | 0.0140 - 0.1500 |
Volume | |
Avg. volume | 40,434 |
Market cap | 1.903M |
Beta (5Y monthly) | 0.14 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ESTERO, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- via IBN -- Mushrooms Inc., (OTC: MSRM) a developing leader in biotechnology and sustainable healthcare innovation using mushrooms and mycelium, is excited to announce a suite of strategic initiatives aimed at transforming the healthcare landscape. These initiatives include the launch of two groundbreaking health supplements, LONGEVITY and SPORT+, and the exploration of a development collaboration with a renowned scientific team in Germany. These e
ESTERO, Fla., Oct. 18, 2023 (GLOBE NEWSWIRE) -- via IBN -- Mushrooms Inc., (OTC: MSRM) a leader in mycelium research and development, proudly announces the successful filing of its non-provisional patent, titled "METHOD OF GENERATING MULTIFUNCTIONAL MYCELIUM PRODUCTS". This revolutionary patent showcases a unique approach to bacterial detection and nutrient delivery, marking a significant shift from the company's previous provisional filing. Kimberly Carlson, CEO of MSRM, remarked, "With the Pha